ConductScience.org, home

Library / Genes

EEF1A1: eukaryotic translation elongation factor 1 alpha 1

1 protein, 94 patents, 0 drugs, 0 trials, 2,960 NIH grants and 4,640 papers.

Gene 7

Its symbol and name are HGNC's, unless HGNC and NCBI Gene contradict each other.

FieldValueSource
SymbolEEF1A1HGNC
Nameeukaryotic translation elongation factor 1 alpha 1HGNC
NCBI Gene ID1915NCBI Gene
HGNC IDHGNC:3189HGNC
EnsemblENSG00000156508NCBI Gene
AliasesCCS-3, CCS3, EE1A1, EEF-1, EEF1A, EF-Tu, EF1A, EF1A1, EF1alpha1, GRAF-1EF, LENG7, PTI1, eEF1A-1NCBI Gene
Typeprotein-codingNCBI Gene

Proteins 1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated inSource
P68104Elongation factor 1-alpha 146213Ensembl, GeneID, HGNCUniProt

Patents 94

Patents whose sequence listing holds the protein exactly: the same sequence, by SHA-256, length and CRC-64. A sequence a patent lists is not always one it claims.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1445396P68104Espacenet
JP 2026004568 A2026-01-1445397P68104Espacenet
JP 2026004568 A2026-01-1445398P68104Espacenet
EP 4641201 A22025-10-295552P68104Espacenet
EP 4641202 A22025-10-295023P68104Espacenet
JP 2025517969 A2025-06-125552P68104Espacenet
KR 1020250017231 A2025-02-045023P68104Espacenet
US 11927591 B22024-03-1214P68104Espacenet
JP 2023064789 A2023-05-1258P68104Espacenet
WO 2023074712 A2023-05-044P68104Espacenet

Drugs 0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource

Trials 0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

TrialDrugPhaseResults first postedSource

NIH grants 2960

NIH projects whose papers are about the gene, through NIH's grant-paper links.

ProjectTitleIts papers about the geneNewest fiscal yearSource
P30CA008748Cancer Center Support Grant172,025NIH's project files
P30CA016672Cancer Center Support Grant142,025NIH's project files
R35GM122602Mechanisms of eukaryotic translation and ribosome-associated mRNA surveillance and protein quality control72,025NIH's project files
P30CA013330Cancer Center Support Grant62,025NIH's project files
RM1HG008935Center for dynamic RNA epitranscriptomes - Renewal62,025NIH's project files
P30CA016058Cancer Center Support Grant52,025NIH's project files
P30CA046934University of Colorado Cancer Center Support Grant52,025NIH's project files
P30CA060553The Robert H. Lurie Comprehensive Cancer Center52,025NIH's project files
R01CA154663TGFbeta-regulated epithelial-mesenchymal transition (EMT)52,025NIH's project files
R35GM118070Structure, function, and dynamics of viral RNAs and RNA-containing complexes52,025NIH's project files

Papers 4640

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

PMIDFound bySource
42824931PubTator, text miningPubMed
42794905PubTator, text miningPubMed
42781876PubTator, text miningPubMed
42780046PubTator, text miningPubMed
42774890PubTator, text miningPubMed
42757385PubTator, text miningPubMed
42655810PubTator, text miningPubMed
42619600PubTator, text miningPubMed
42545605PubTator, text miningPubMed
42469336PubTator, text miningPubMed

The same record as JSON

Release gene-search-2026-11-11-0.1.0

ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

ChEMBL, through Open Targets: CC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

EMBL-EBI's patent proteins: EMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use

GenBank's patent files: GenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/

HGNC: CC0: https://www.genenames.org/about/license/

NCBI Gene: None named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/

NIH's project files and grant-paper links: Public domain (NIH RePORTER)

Open Targets: CC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence

PubTator 3: Public domain

UniProt: CC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license